Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Hajipouran Benam, R. Villenave, C. Lucchesi, M. Mazur, G. Hamilton, D. Ingber (Boston, United States Of America). Development of a human COPD model-on-a-chip to mimic disease exacerbation (a small airway-on-a-chip model). Eur Respir J 2014; 44: Suppl. 58, 3340

Member's Comments

No comment yet.

Related content which might interest you: Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Can red blood cell morphology be an indicator for COPD exacerbations? Source: International Congress 2014 – Markers Year: 2014 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Cells biomarkers of bronchial brush-biopsies at COPD exacerbation Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Comparison of inflammatory markers in induced and spontaneous sputum in COPD patients Source: International Congress 2014 – Translational studies in COPD Year: 2014 Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Activin-A expression in COPD exacerbations: Local index of airway inflammation? Preliminary results Source: International Congress 2014 – Mechanisms of COPD and inhalation injury Year: 2014 Value of adding treatment with lyophilized bacterial lysates in reducing COPD exacerbations in COPD patients risk group C and D Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Endothelial dysfunction and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – COPD physiopathology Year: 2014 PPAR-alpha agonist (fenofibrate) therapy in exacerbation control of chronic obstructive pulmonary disease of severe stage Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs Year: 2014 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Blood eosinophils, exacerbations in the previous year, lung function and ICS dose predict frequent exacerbations in asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Effects of ICS/LABA treatment on hyperinflation and genome wide gene-expression in upper airway epithelium in severe COPD Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma Year: 2016 Holding chamber (Spacer) - A potential harbor of pathogenic bacteria Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014